Overview:
The management of esophagogastric adenocarcinoma has evolved substantially with the introduction of effective targeted and immunologic therapies. However, these therapies are appropriate mainly for patients with specific biomarkers, necessitating careful coordination among the multidisciplinary team to ensure proper tissue stewardship and testing, which in turn allows for appropriate treatment selection and sequencing, as well as management and mitigation of adverse events.
In this live, virtual webcast, experts in the management of
esophagogastric adenocarcinoma discuss recent changes in the standard of care
for HER2-positive disease, with a focus on selecting among multiple available
options. These points will be discussed in the context of patient case
scenarios that highlight challenges in the management of HER2-positive
esophagogastric cancers.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Incorporate the latest evidence on HER2-directed therapies into individualized treatment plans for patients with advanced GEA
- Evaluate emerging clinical trial data assessing novel HER2-targeted treatment strategies for GEA
Target Audience:
This educational program is primarily directed toward
medical oncologists, molecular pathologists, radiologists, gastroenterologists,
advanced practice providers, and nurses who are involved in the management of
patients with advanced or metastatic gastroesophageal adenocarcinomas (GEA).
Pashtoon Kasi, MD, MS
Associate Clinical Professor
Department of Medical Oncology & Therapeutics Research
Medical Director of GI Medical Oncology
City of Hope
Irvine, CA
Simona De Michele, MD
Assistant Clinical Professor
Department of Pathology
City of Hope
Irvine, CA
Elizabeth Conner, MD
Assistant Clinical Professor
City of Hope
Irvine, CA
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’
Education Resource®, LLC is approved by the California Board of
Registered Nursing, Provider #16669, for 1.0 Contact Hour.